HINGHAM, Mass. , Sept. 07, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that Hezi Himelfarb , General Manager and Chief Operating Officer, is
Investor Update Conference Call today at 5:00pm ET HINGHAM, Mass. , Aug. 14, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today reported financial and
Conference Call Scheduled for Monday, August 14th at 5:00pm ET HINGHAM, Mass. , Aug. 10, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, will release second
HINGHAM, Mass. , June 14, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that the United States Patent and Trademark Office (“USPTO”) has
HINGHAM, Mass. , June 09, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, closed its previously announced registered direct offering of 3,750,000 shares of
